Cargando…

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping

The incidence of cervical cancer is expected to rise sharply in China. A reliable routine human papillomavirus (HPV) detection and genotyping test to be supplemented by the limited Papanicolaou cytology facilities is urgently needed to help identify the patients with cervical precancer for preventiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Shichao, Gong, Bo, Cai, Xushan, Yang, Xiaoer, Gan, Xiaowei, Tong, Xinghai, Li, Haichuan, Zhu, Meijuan, Yang, Fengyun, Zhou, Hongrong, Hong, Guofan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544437/ https://www.ncbi.nlm.nih.gov/pubmed/23342254 http://dx.doi.org/10.1002/cam4.9

Ejemplares similares

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China
por: Wang, Yuli, et al.
Publicado: (2018)

Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women
por: Johnson, Lauren G., et al.
Publicado: (2020)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high‐risk human papillomavirus cervical carcinomas
por: Liu, Jing Jing, et al.
Publicado: (2020)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
por: Clarke, Megan A., et al.
Publicado: (2021)

Geographical disparities in human papillomavirus herd protection
por: Berenson, Abbey B., et al.
Publicado: (2020)

A cross‐sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women
por: Wu, Qiongyan, et al.
Publicado: (2017)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
por: Huang, Cheng‐Chih, et al.
Publicado: (2021)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia
por: Zhang, Chaoting, et al.
Publicado: (2018)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection
por: Vriend, Henrike J, et al.
Publicado: (2015)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women
por: Zhu, Bo, et al.
Publicado: (2019)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme
por: Macios, Anna, et al.
Publicado: (2021)

Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population
por: Zhang, Meijuan, et al.
Publicado: (2016)

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants
por: Madeleine, Margaret M, et al.
Publicado: (2014)

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study
por: Hammer, Anne, et al.
Publicado: (2019)

Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV‐positive women attending public health centers in Addis Ababa city, Ethiopia
por: Shiferaw, Saba, et al.
Publicado: (2018)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Inverse association of Helicobacter pylori cagPAI genotypes with risk of cardia and non‐cardia gastric adenocarcinoma
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2019)

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
por: Hu, Zheng, et al.
Publicado: (2018)

Implementing the 3T‐approach for cervical cancer screening in Cameroon: Preliminary results on program performance
por: Levy, Juliette, et al.
Publicado: (2020)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Benard, Vicki B., et al.
Publicado: (2021)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

Spatial distribution characteristics of tumor marker CA724 reference values in China
por: Jing, Jing, et al.
Publicado: (2019)

Evidence‐based policy choices for efficient and equitable cervical cancer screening programs in low‐resource settings
por: Campos, Nicole G., et al.
Publicado: (2017)

Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3(Tyr705) phosphorylation
por: Sun, Xiaodong, et al.
Publicado: (2020)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Letter to the Editor Re: A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Castle, Philip E.
Publicado: (2021)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

A population‐based study of age‐related associations between vaginal pH and the development of cervical intraepithelial neoplasia
por: Teng, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_drr944akhb0dadeu86f0cnueb7